Gene therapy milestone looms, but field seeks better options.
Where this comes from
- Record sourced from PubMed, PMID 37228210.
- Also identified by DOI 10.1126/science.adi8792.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
FDA is expected to endorse Duchenne muscular dystrophy treatment, as safety concerns linger over uses of viruses.
Medical subject headings
- Genetic Therapy
- Muscular Dystrophy, Duchenne